TG103
A Study of TG103 Injection in Overweight/Obese Subjects Without Diabetes
CSPC Baike (Shandong) Biopharmaceutical Co · Phase 1 · Completed · Enrollment 48
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.